Notre Dame will lead a National Nuclear Security Administration (NNSA) Actinide Center of Excellence to conduct research in actinide and nuclear chemistry. The NNSA’s Stewardship Sciences Academic Alliance program will provide $12.5 million for the center, which is tasked with prioritizing research that is important for Stockpile Stewardship—the certification that the nation’s nuclear weapons are secure and operational.
Marya Lieberman, professor of chemistry and biochemistry, was featured as a member of the Notre Dame All-Faculty Team on Oct. 28 during the football game against North Carolina State.
What started as a small event in 2014 among Notre Dame’s community of soft matter and polymer researchers, has now grown into an annual regional symposium that includes faculty presentations and student posters from four universities.
Research took precedence over relaxation for several College of Science students this summer who spent 10 weeks completing undergraduate research projects at MD Anderson Cancer Center in Houston, Texas.
Determining how proteins function on a molecular level is crucial to understanding the underlying basis for disease. Now scientists at the University of Notre Dame are one step closer to unraveling the mystery of how intrinsically disordered proteins work, according to new research published in Science.
The fourth-year doctoral student in the Department of Chemistry and Biochemistry is one of ten 2017 recipients of the high-profile Graduate Research Fellowship in STEM from the National Institute of Justice (NIJ).
Sharon Stack
Two papers involving ovarian cancer research at the University of Notre Dame’s Harper Cancer Research Institute (HCRI), one featuring new research and the other a review article, were published as cover stories in their respective journals.
Colorectal cancer patients may benefit by avoiding sweets for three days before chemotherapy and by taking a common antimalaria drug, according to new research by biochemistry doctoral student Monica Schroll.
Researchers at the Harper Cancer Research Institute, which is a collaboration between the University of Notre Dame and the Indiana University School of Medicine South Bend (IUSM-SB), are working with community partners to not only foster awareness of ovarian cancer, but to develop tests for early detection, create novel chemotherapies, and target the Holy Grail: A cure.
The University of Notre Dame’s Advanced Diagnostics & Therapeutics (AD&T) initiative announced the recipients of its 2017 Discovery Fund awards, which provide seed funding to some of the most creative ideas being developed by Notre Dame faculty and their collaborators in areas of biomedical, environmental, and behavioral health.
We are delighted to welcome Dr. Arnaldo Serrano to the faculty at Notre Dame as an Assistant Professor of Chemistry & Biochemistry. At Notre Dame, Dr. Serrano plans to develop new nonlinear imaging techniques such as time-resolved nonlinear and multidimensional microscopies.
Richard E. Taylor, professor of chemistry and biochemistry at the University of Notre Dame, has been named interim director of Notre Dame California. He succeeds Patrick J. Flynn, Duda Family Professor of Engineering, who served as interim director from July 2016 through June of this year. As of July 1, Flynn assumed the position of chair of the University’s Department of Computer Science and Engineering.
Dr. Tyvette Hilliard, a postdoctoral fellow in the laboratory of Dr. Sharon Stack, Director of Harper Cancer Research Institute, has received a highly competitive 5-year K01 Research Career Development award from the NIH/NCI.
Notre Dame International is providing funding to build, sustain, and encourage academic and research collaboration with leading universities in Mexico.
When it comes to ovarian cancer, 60 percent of patients are diagnosed in stage III, meaning the cancer has already metastasized, or spread, throughout the pelvis. Additionally, between 70 and 90 percent of those patients will be diagnosed with recurrence and although recurrent ovarian cancer is treatable, it is rarely curable. These unfortunate results are partially due to the disease’s ability to spread cancer cells and therefore efficiently penetrate other organs. To better understand how metastatic ovarian cancer spreads, Notre Dame researchers at the Harper Cancer Research Institute (HCRI) are evaluating the impact of ovarian cancer cell molecular composition and how these cells work together to invade surrounding tissue.
Two University of Notre Dame graduate students, Enrico Speri and Yide Zhang, have been awarded the 2017 Berry Family Foundation Graduate Fellowships in Advanced Diagnostics & Therapeutics to support their exceptional and wide-ranging research programs—which touch on aspects of biology, chemistry, and engineering—over the next academic year.
Brian Blagg, Ph.D., currently the Lester and Betty Mitscher Professor of Medicinal Chemistry at the University of Kansas, will join the University of Notre Dame as the incoming director of the Warren Family Research Center for Drug Discovery and Development and the Charles Huisking Professor of Chemistry & Biochemistry, according to Mary E. Galvin, William K. Warren Dean of the College of Science.
Scientists have been aware since Watson and Crick first reported the double helix structure of DNA in 1953 that water had an important relationship with the biomolecule. But finally observing the spectroscopic signature of the column of water is a breakthrough with implications for cancer drugs and other biomedical research.
More than 500 students attended the 11th College of Science Joint Annual Meeting (COS-JAM) on Friday, May 5, in the Jordan Hall of Science. The event highlighted the research achievements of undergraduate students and is part of the Undergraduate Scholars Conference.
Researchers within ND Energy are thinking creatively about problems surrounding nuclear materials and are searching for solutions to reduce waste, decrease the cost of nuclear energy production, and increase efficiency and safety of the entire process.